Author/Authors :
Ahmadi، Alireza نويسنده Assistant Professor, Isfahan Cardiovascular Research Centre, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran , , Sabri، Mohammadreza نويسنده Professor, Department of Pediatrics, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran , , Bigdelian، Hamid نويسنده Cardiac Surgery, Isfahan University of Medical Sciences, Isfahan , , Dehghan، Bahar نويسنده Fellow of Pediatric Cardiology, Department of Pediatrics, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran , , Gharipour، Mojgan نويسنده Hypertension Research Center, Isfahan Cardiovascular Research Institute, IUMS, Isfahan ,
Abstract :
BACKGROUND: Various devices have been recently employed for percutaneous closure of the
patent ductus arteriosus (PDA). Although the high effectiveness of device closure techniques has
been clearly determined, a few studies have focused on the cost-effectiveness and also
postoperative complications of these procedures in comparison with open surgery. The present
study aimed to evaluate the clinical outcome and cost-effectiveness of PDA occlusion by
Amplatzer and coil device in comparisong with open surgery.
METHODS: In this cross-sectional study, a randomized sample of 201 patients aged 1 month to
16 years (105 patients with device closure and 96 patients with surgical closure) was selected.
The ratio of total pulmonary blood flow to total systemic blood flow, the Qp/Qs ratio, was
measured using a pulmonary artery catheter. The cost analysis included direct medical care
costs associated with device implantation and open surgery, as well as professional fees. All
costs were calculated in Iranian Rials and then converted to US dollars.
RESULTS: There was no statistical difference in mean Qp/Qs ratio before the procedure between
the device closure group and the open surgery group (2.1 ± 0.7 versus 1.7 ± 0.6, P = 0.090). The
mean measured costs were overall higher in the device closure group than in open closure group
(948.87 ± 548.76 US$ versus 743.70 ± 696.91 US$, P < 0.001). This difference remained
significant after adjustment for age and gender (Standardized Beta = 0.160, P = 0.031). PDA
closure with the Amplatzer ductal occluder (1053.05 ± 525.73 US$) or with Nit-Occlud coils
(PFM) (912.73 ± 565.94 US$, P < 0.001) was more expensive than that via open surgery.
However, the Cook detachable spring coils device closure (605.65 ± 194.62 US$, P = 0.650) had
a non-significant cost difference with open surgery. No event was observed in the device closure
group regarding in-hospital mortality or morbidity; however, in another group, 2 in-hospital
deaths occurred, two patients experienced pneumonia and seizure, and one suffered electrolyte
abnormalities including hyponatremia and hypocalcemia.
CONCLUSION: Although open surgery seems to be less expensive than device closure technique,
because of lower mortality and morbidity, the latter group is more preferable.